Viewing Study NCT05242432


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-01-02 @ 4:11 AM
Study NCT ID: NCT05242432
Status: TERMINATED
Last Update Posted: 2025-05-23
First Post: 2022-02-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese Participants
Sponsor: Janssen Pharmaceutical K.K.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module